Albion Enterprise VCT PLC
As required by the UK Listing Authority's Disclosure and Transparency Rule 4.2, Albion Enterprise VCT PLC today makes public its information relating to the Half-yearly Financial Report (which is unaudited) for the six months to 30 September 2015. This announcement was approved by the Board of Directors on 26 November 2015.
The full Half-yearly Financial Report (which is unaudited) for the period to 30 September 2015, will shortly be sent to shareholders. Copies of the full Half-yearly Financial Report will be shown via the Albion Ventures LLP website by clicking www.albion-ventures.co.uk/ourfunds/AAEV.htm.
Investment objective and policy
The investment objective of Albion Enterprise VCT PLC ("the Company") is to provide investors with a regular and predictable source of income, combined with the prospect of longer term capital growth.
The Company achieves this by investing up to 50 per cent. of the net funds raised in an asset-based portfolio of more stable businesses (the "Asset-based Portfolio"). The balance of the net funds raised, other than funds retained for liquidity purposes, are invested in a portfolio of higher growth businesses across a variety of sectors of the UK economy. These range from more stable, income producing businesses to higher risk technology companies (the "Growth Portfolio"). In neither category do portfolio companies normally have any external borrowing with a charge ranking ahead of the Company. Up to two-thirds of qualifying investments by cost comprise loan stock secured with a first charge on the portfolio company's assets. Funds awaiting investment in Qualifying Investments or retained for liquidity purposes are held on deposit or invested in floating rate notes with banks or other financial institutions with high credit ratings assigned by international credit ratings agencies.
The Company's investment portfolio is structured to provide a balance between income and capital growth for the longer term. The Asset-based Portfolio is designed to provide stability and income whilst still maintaining the potential for capital growth. The Growth Portfolio is intended to provide diversified exposure through its portfolio of investments in unquoted UK companies. Stock specific risk will be reduced by the Company's policy of holding a diversified portfolio of Qualifying Investments.
Financial calendar
Record date for second dividend | 12 February 2016 |
Payment date for second dividend | 29 February 2016 |
Financial year end | 31 March 2016 |
Financial highlights
Unaudited six months ended 30 September 2015 | Unaudited six months ended 30 September 2014 | Audited year ended 31 March 2015 | |
(pence per share) | (pence per share) | (pence per share) | |
Dividends paid | 2.50 | 2.50 | 5.00 |
Revenue return | 0.94 | 0.94 | 2.07 |
Capital return | 3.16 | 0.30 | 2.18 |
Net asset value | 97.68 | 95.67 | 96.22 |
Total shareholder return to 30 September 2015 | (pence per share) |
Dividends paid during the year ended: | |
31 March 2008 | 0.70 |
31 March 2009 | 1.65 |
31 March 2010 | 2.00 |
31 March 2011 | 3.00 |
31 March 2012 | 3.00 |
31 March 2013 | 3.50 |
31 March 2014 | 5.00 |
31 March 2015 | 5.00 |
Dividends paid in the six months to 30 September 2015 | 2.50 |
Total dividends paid to 30 September 2015 | 26.35 |
Net asset value as at 30 September 2015 | 97.68 |
Total shareholder return to 30 September 2015 | 124.03 |
In addition to the dividends summarised above, the Directors have declared a second dividend of 2.50 pence per share, payable on 29 February 2016 to shareholders on the register at 12 February 2016.
Notes
Interim management report
Introduction
I am pleased to announce that the Company achieved a total return for the six months to 30 September 2015 of 4.1 pence per share compared to 1.2 pence per share for the same period last year. These results reflect positive developments in a number of our portfolio companies and we are encouraged to see a further 11 per cent. increase in income received.
Investment progress and prospects
During the period £1.6 million was invested in existing and new companies, including £635,000 into Radnor House School to help develop Combe Bank School in Kent, which was bought earlier in the year. There were no exits during the period, although £624,000 was received through the repayment of loan stock by Masters Pharmaceuticals and Hilson Moran.
In general, the investment portfolio continues to perform well, with continued growth at Radnor House School, which now has 390 pupils and recorded strong GCSE results. Encouraging growth was also seen in Exco Intouch, MyMeds&Me, Hilson Moran, Grapeshot and Egress.
Changes in VCT legislation
The July budget introduced a number of changes to VCT legislation, including restrictions over the age of investments, a prohibition on management buyouts or the purchase of existing businesses and an overall lifetime investment cap of £12m from tax-advantaged funds into any portfolio company. While these changes are significant, the Company has been advised that had they been in place previously they would have affected only a relatively small minority of the investments that we have made into new portfolio companies over recent years. The Board's current view is that there will be no material change in our investment policy as a result.
Risks & uncertainties
The outlook for the UK and global economies continues to be the key risk affecting the Company, despite continued growth in the UK. Investment risk is mitigated in a number of ways, including our policy that the portfolio should be balanced across sectors and it should include a significant level of asset backing.
Other risks and uncertainties remain unchanged and are as detailed on pages 11 and 12 in the Strategic report of the Annual Report and Financial Statements for the year ended 31 March 2015.
Discount management and share buy-backs
It remains the Board's policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company's interest, including the maintenance of sufficient resources for investment in new and existing portfolio companies and the continued payment of dividends to shareholders. It is the Board's intention for such buy-backs to be in the region of a 5 per cent. discount to net asset value so far as market conditions and liquidity permit.
Transactions with the Manager
Details of the transactions that took place with the Manager during the period can be found in note 5.
There are no related party transactions or balances that require disclosure.
Albion VCTs Prospectus Top Up Offers
The launch of the Albion VCTs Prospectus Top Up Offers 2015/16 was announced on 17 November 2015 with the aim of raising £25.5m across the six Albion VCTs, including Albion Enterprise VCT PLC. There is an "Early Bird" offer for subscribers who apply by 29 January 2016. The 2014/15 Top Up Offers raised £34.7 million in aggregate, including £5.7 million for the Company.
Results and dividends
As at 30 September 2015, the net asset value was £39.5 million or 97.7 pence per share compared to £34.7 million or 96.2 pence per share at 31 March 2015. The revenue return before taxation was £451,000 compared to £401,000 for the six months to 30 September 2014. In line with the annual dividend target of 5 pence per share, the Directors declare a second dividend for the year of 2.5 pence per share payable on 29 February 2016 to shareholders on the register as at 12 February 2016.
M Packe
Chairman
26 November 2015
Responsibility statement
The Directors, Maxwell Packe, Lady Balfour of Burleigh, Lord St. John of Bletso and Patrick Reeve, are responsible for preparing the Half-yearly Financial Report. In preparing these condensed Financial Statements for the period to 30 September 2015 we, the Directors of the Company, confirm that to the best of our knowledge:
This Half-yearly Financial Report has not been audited or reviewed by the Auditor.
By order of the Board
M Packe
Chairman
26 November 2015
Portfolio of investments
The following is a summary of fixed asset investments as at 30 September 2015:
Fixed asset investments | % voting rights held by the Company | Cost £'000 | Cumulative movement in value £'000 | Value £'000 | Change in value for the period* £'000 | |
Asset-based investments | ||||||
Radnor House School (Holdings) Limited | 9.8 | 3,323 | 1,972 | 5,295 | 484 | |
Bravo Inns II Limited | 13.1 | 2,150 | 49 | 2,199 | 14 | |
Regenerco Renewable Energy Limited | 12.5 | 1,263 | 371 | 1,634 | 65 | |
Greenenerco Limited | 28.6 | 1,000 | 519 | 1,519 | 21 | |
Earnside Energy Limited (formerly TEG Biogas (Perth) Limited) | 16.4 | 1,314 | 195 | 1,509 | (83) | |
Alto Prodotto Wind Limited | 11.1 | 1,000 | 483 | 1,483 | 21 | |
The Street by Street Solar Programme Limited | 8.6 | 894 | 379 | 1,273 | 45 | |
Bravo Inns Limited | 8.4 | 755 | (264) | 491 | 3 | |
AVESI Limited | 5.5 | 181 | 48 | 229 | 11 | |
The Charnwood Pub Company Limited | 1.2 | 235 | (152) | 83 | (19) | |
Total asset-based investments | 12,115 | 3,600 | 15,715 | 562 | ||
Growth investments | ||||||
Mirada Medical Limited | 15.1 | 800 | 898 | 1,698 | 9 | |
Exco Intouch Limited | 6.0 | 1,015 | 420 | 1,435 | 378 | |
Egress Software Technologies Limited | 8.8 | 880 | 271 | 1,151 | 91 | |
Relayware Limited | 6.3 | 1,065 | 50 | 1,115 | 17 | |
Masters Pharmaceuticals Limited | 7.3 | 553 | 533 | 1,086 | 40 | |
DySIS Medical Limited | 8.4 | 1,439 | (372) | 1,067 | (46) | |
Process Systems Enterprise Limited | 3.9 | 365 | 621 | 986 | 53 | |
Hilson Moran Holdings Limited | 10.0 | 271 | 538 | 809 | 193 | |
Grapeshot Limited | 5.0 | 629 | 117 | 746 | 117 | |
Mi-Pay Group PLC | 6.3 | 1,504 | (793) | 711 | 196 | |
Cisiv Limited | 8.1 | 522 | 185 | 707 | 16 | |
OmPrompt Holdings Limited | 5.3 | 650 | 15 | 665 | 4 | |
MyMeds&Me Limited | 5.4 | 418 | 228 | 646 | 229 | |
Abcodia Limited | 6.5 | 555 | 72 | 627 | 36 | |
Aridhia Informatics Limited | 2.3 | 909 | (302) | 607 | (95) | |
Proveca Limited | 8.3 | 470 | 120 | 590 | (74) | |
memsstar Limited | 8.8 | 384 | 192 | 576 | 5 | |
Oxsensis Limited | 3.8 | 588 | (330) | 258 | - | |
Silent Herdsman Holdings Limited | 11.3 | 466 | (223) | 243 | (82) | |
Lowcosttravelgroup Limited | 1.0 | 270 | (138) | 132 | (141) | |
Sandcroft Avenue Limited (payasUgym.com) | 1.7 | 112 | 15 | 127 | 28 | |
Total growth investments | 13,865 | 2,117 | 15,982 | 974 | ||
Total fixed asset investments | 25,980 | 5,717 | 31,697 | 1,536 |
*As adjusted for additions and disposals during the period.
Total change in value of investments for the period | 1,536 | |||||
Movement in loan stock accrued interest | (14) | |||||
Unrealised gains sub-total | 1,522 | |||||
Realised gain in current period | 7 | |||||
Total gains on investments as per Income statement | 1,529 |
Fixed asset realisations | Cost £'000 | Opening carrying value £'000 | Disposal proceeds £'000 | Total realised gain £'000 | Gain on opening value £'000 |
Masters Pharmaceuticals Limited (loan stock and redemption premium repayment) | 440 | 545 | 552 | 112 | 7 |
Radnor House School (Holdings) Limited (loan stock repayment) | 88 | 88 | 88 | - | - |
Hilson Moran Holdings Limited (loan stock and redemption premium repayment) | 53 | 72 | 72 | 19 | - |
The Charnwood Pub Company Limited (loan stock repayment) | 13 | 13 | 13 | - | - |
Total fixed asset realisations | 594 | 718 | 725 | 131 | 7 |
Condensed income statement
Unaudited six months ended 30 September 2015 | Unaudited six months ended 30 September 2014 | Audited year ended 31 March 2015 | ||||||||
Note | Revenue £'000 | Capital £'000 | Total £'000 | Revenue £'000 | Capital £'000 | Total £'000 | Revenue £'000 | Capital £'000 | Total £'000 | |
Gains on investments | 3 | - | 1,529 | 1,529 | - | 348 | 348 | - | 1,264 | 1,264 |
Investment income | 4 | 678 | - | 678 | 606 | - | 606 | 1,258 | - | 1,258 |
Investment management fees | 5 | (116) | (347) | (463) | (103) | (309) | (412) | (210) | (628) | (838) |
Other expenses | (111) | - | (111) | (102) | - | (102) | (201) | - | (201) | |
Return on ordinary activities before taxation | 451 | 1,182 | 1,633 | 401 | 39 | 440 | 847 | 636 | 1,483 | |
Tax (charge)/credit on ordinary activities | (80) | 69 | (11) | (75) | 65 | (10) | (119) | 131 | 12 | |
Return attributable to shareholders | 371 | 1,251 | 1,622 | 326 | 104 | 430 | 728 | 767 | 1,495 | |
Basic and diluted return per share (pence)* | 7 | 0.94 | 3.16 | 4.10 | 0.94 | 0.30 | 1.24 | 2.07 | 2.18 | 4.25 |
* excluding treasury shares
Comparative figures have been extracted from the unaudited Half-yearly Financial Report for the six months ended 30 September 2014 and the audited statutory accounts for the year ended 31 March 2015.
The accompanying notes form an integral part of this Half-yearly Financial Report.
The total column of this condensed income statement represents the profit and loss account of the Company. The supplementary revenue and capital columns have been prepared in accordance with The Association of Investment Companies' Statement of Recommended Practice.
All revenue and capital items in the above statement derive from continuing operations.
There are no recognised gains or losses other than the results for the periods disclosed above. Accordingly a Statement of comprehensive income is not required. The difference between the reported return on ordinary activities before tax and the historical profit is due to the fair value movements on investments. As a result a note on historical cost profit and losses has not been prepared.
Condensed balance sheet
Note | Unaudited 30 September 2015 £'000 | Unaudited 30 September 2014 £'000 | Audited 31 March 2015 £'000 | |
Fixed asset | ||||
Investments | 31,697 | 28,508 | 29,283 | |
Current assets | ||||
Trade and other receivables less than one year | 670 | 757 | 66 | |
Cash and cash equivalents | 7,481 | 4,771 | 5,621 | |
8,151 | 5,528 | 5,687 | ||
Total assets | 39,848 | 34,036 | 34,970 | |
Creditors: amounts falling due within one year | ||||
Trade and other payables less than one year | (372) | (291) | (308) | |
Net assets | 39,476 | 33,745 | 34,662 | |
Equity attributable to equityholders | ||||
Called up share capital | 8 | 457 | 395 | 409 |
Share premium | 11,455 | 5,572 | 6,969 | |
Capital redemption reserve | 104 | 104 | 104 | |
Unrealised capital reserve | 5,588 | 4,299 | 4,189 | |
Realised capital reserve | 666 | 41 | 814 | |
Other distributable reserve | 21,206 | 23,334 | 22,177 | |
Total equity shareholders' funds | 39,476 | 33,745 | 34,662 | |
Basic and diluted net asset value per share (pence)* | 97.68 | 95.67 | 96.22 |
* excluding treasury shares
Comparative figures have been extracted from the unaudited Half-yearly Financial Report for the six months ended 30 September 2014 and the audited statutory accounts for the year ended 31 March 2015.
The accompanying notes form an integral part of this Half-yearly Financial Report.
These Financial Statements were approved by the Board of Directors, and authorised for issue on 26 November 2015 and were signed on its behalf by
M Packe
Chairman
Company number 05990732
Condensed statement of changes in equity
Called up share capital £'000 | Share premium £'000 | Capital redemption reserve £'000 | Unrealised capital reserve £'000 | Realised capital reserve* £'000 | Other distributable reserve* £'000 | Total £'000 | |
As at 1 April 2015 | 409 | 6,969 | 104 | 4,189 | 814 | 22,177 | 34,662 |
Return/(loss) and total comprehensive income for the period | - | - | - | 1,522 | (271) | 371 | 1,622 |
Transfer of previously unrealised gains | - | - | - | (123) | 123 | - | - |
Purchase of shares for treasury | - | - | - | - | - | (343) | (343) |
Issue of equity | 48 | 4,624 | - | - | - | - | 4,672 |
Cost of issue of equity | - | (138) | - | - | - | - | (138) |
Equity dividends paid | - | - | - | - | - | (999) | (999) |
As at 30 September 2015 | 457 | 11,455 | 104 | 5,588 | 666 | 21,206 | 39,476 |
As at 1 April 2014 | 367 | 3,015 | 104 | 4,164 | 72 | 24,334 | 32,056 |
Return/(loss) and total comprehensive income for the period | - | - | - | 300 | (196) | 326 | 430 |
Transfer of previously unrealised gains | - | - | - | (165) | 165 | - | - |
Purchase of shares for treasury | - | - | - | - | - | (451) | (451) |
Issue of equity | 28 | 2,617 | - | - | - | - | 2,645 |
Cost of issue of equity | - | (60) | - | - | - | - | (60) |
Equity dividends paid | - | - | - | - | - | (875) | (875) |
As at 30 September 2014 | 395 | 5,572 | 104 | 4,299 | 41 | 23,334 | 33,745 |
As at 1 April 2014 | 367 | 3,015 | 104 | 4,164 | 72 | 24,334 | 32,056 |
Return and total comprehensive income for the period | - | - | - | 649 | 118 | 728 | 1,495 |
Transfer of previously unrealised gains | - | - | - | (624) | 624 | - | - |
Purchase of shares for treasury | - | - | - | - | - | (1,094) | (1,094) |
Issue of equity | 42 | 4,045 | - | - | - | - | 4,087 |
Cost of issue of equity | - | (91) | - | - | - | - | (91) |
Equity dividends paid | - | - | - | - | - | (1,791) | (1,791) |
As at 31 March 2015 | 409 | 6,969 | 104 | 4,189 | 814 | 22,177 | 34,662 |
* Included within the aggregate of these reserves is an amount of £21,872,000 (30 September 2014: £23,375,000; 31 March 2015: £22,991,000) which is considered distributable.
Condensed statement of cash flows
Note | Unaudited six months ended 30 September 2015 £'000 | Unaudited six months ended 30 September 2014 £'000 | Audited year ended 31 March 2015 £'000 | |
Cash flow from operating activities | ||||
Loan stock income received | 572 | 535 | 1,047 | |
Deposit interest received | 42 | 35 | 65 | |
Dividend income received | 50 | 47 | 84 | |
Investment management fees paid | (433) | (401) | (823) | |
Other cash payments | (122) | (118) | (203) | |
Corporation tax refund/(paid) | 35 | - | (15) | |
Net cash flow from operating activities | 9 | 144 | 98 | 155 |
Cash flow from investing activities | ||||
Purchase of fixed asset investments | (1,594) | (1,780) | (4,918) | |
Disposal of fixed asset investments | 739 | 226 | 3,579 | |
Disposal of current asset investments | - | 69 | 177 | |
Net cash flow from investing activities | (855) | (1,485) | (1,162) | |
Cash flow from financing activities | ||||
Issue of ordinary share capital | 3,748 | 1,872 | 3,791 | |
Cost of issue of equity | (2) | (1) | (3) | |
Equity dividends paid (net of costs of shares issued under the Dividend Reinvestment Scheme) | (861) | (776) | (1,580) | |
Purchase of own shares (including costs) | (314) | (451) | (1,094) | |
Net cash flow from financing activities | 2,571 | 644 | 1,114 | |
Increase/(decrease) in cash and cash equivalents | 1,860 | (743) | 107 | |
Cash and cash equivalents at start of period | 5,621 | 5,514 | 5,514 | |
Cash and cash equivalents at end of period | 7,481 | 4,771 | 5,621 | |
Cash and cash equivalents comprise | ||||
Cash at bank and in hand | 7,481 | 4,771 | 5,621 | |
Cash equivalents | - | - | - | |
Total cash and cash equivalents | 7,481 | 4,771 | 5,621 |
Notes to the condensed Financial Statements
1. Basis of preparation
The condensed Financial Statements have been prepared in accordance with the historical cost convention, modified to include the revaluation of investments, in accordance with applicable United Kingdom law and accounting standards, including Financial Reporting Standard 102 ("FRS 102"), and with the 2014 Statement of Recommended Practice "Financial Statements of Investment Trust Companies and Venture Capital Trusts" ("SORP") issued by The Association of Investment Companies ("AIC"). This is the first period in which the financial statements have been prepared under FRS 102. On adoption of, and in accordance with, FRS 102, loans and receivables previously measured at amortised cost using the effective interest rate method less impairment have been classified at fair value through profit and loss ("FVTPL"). This has not led to a material change in value and so has not led to a restatement of comparatives.
The half-yearly report has not been audited, nor has it been reviewed by the auditor pursuant to the FRC's guidance on Review of interim financial information.
2. Accounting policies
Fixed asset investments
The Company's business is investing in financial assets with a view to profiting from their total return in the form of income and capital growth. This portfolio of financial assets is managed and its performance evaluated on a fair value basis, in accordance with a documented investment policy, and information about the portfolio is provided internally on that basis to the Board.
Upon initial recognition (using trade date accounting) investments are classified by the Company as 'at fair value through profit or loss' and are included at their initial fair value, which is cost (excluding expenses incidental to the acquisition which are written off to the income statement).
Subsequently, the investments are valued at 'fair value', which is measured as follows:
Investments are recognised as financial assets on legal completion of the investment contract and are de-recognised on legal completion of the sale of an investment.
Dividend income is not recognised as part of the fair value movement of an investment, but is recognised separately as investment income through the other distributable reserve when a share becomes ex-dividend.
In accordance with the requirements of FRS 102, those undertakings in which the Company holds more than 20 per cent. of the equity as part of an investment portfolio are not accounted for using the equity method. In these circumstances the investment is measured at fair value through profit and loss.
Investment income
Unquoted equity income
Dividend income is included in revenue when the investment is quoted ex-dividend.
Unquoted loan stock and other preferred income
Fixed returns on non-equity shares and debt securities are recognised when the Company's right to receive payment and expected settlement is established.
Bank interest income
Interest income is recognised on an accruals basis using the rate of interest agreed with the bank.
Investment management fees and other expenses
All expenses have been accounted for on an accruals basis. Expenses are charged through the revenue account except the following which are charged through the realised capital reserve:
Taxation
Taxation is applied on a current basis in accordance with FRS 102. Current tax is tax payable (refundable) in respect of the taxable profit (tax loss) for the current period or past reporting periods using the tax rates and laws that have been enacted or substantively enacted at the financial reporting date. Taxation associated with capital expenses is applied in accordance with the SORP.
Deferred tax is provided in full on all timing differences at the reporting date. Timing differences are differences between taxable profits and total comprehensive income as stated in the financial statements that arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in the financial statements.
Reserves
Share premium account
This reserve accounts for the difference between the price paid for shares and the nominal value of the share, less issue costs and transfers to the other distributable reserve.
Capital redemption reserve
This reserve accounts for amounts by which the issued share capital is diminished through the repurchase and cancellation of the Company's own shares.
Unrealised capital reserve
Increases and decreases in the valuation of investments held at the year end against cost are included in this reserve.
Realised capital reserve
The following are disclosed in this reserve:
Other distributable reserve
The special reserve, treasury share reserve and the revenue reserve were combined in 2013 to form a single reserve named other distributable reserve.
This reserve accounts for movements from the revenue column of the Income statement, the payment of dividends, the buyback of shares and other non-capital realised movements.
Dividends
Dividends by the Company are accounted for in the period in which the dividend is paid or approved at the Annual General Meeting.
3. Gains on investments
Unaudited six months ended 30 September 2015 £'000 | Unaudited six months ended 30 September 2014 £'000 | Audited year ended 31 March 2015 £'000 | |
Unrealised gains on fixed asset investments held at fair value through profit or loss | 1,522 | 300 | 649 |
Unrealised gains sub-total | 1,522 | 300 | 649 |
Realised gains on fixed asset investments held at fair value through profit or loss | 7 | 9 | 583 |
Realised gains on current asset investments held at fair value through profit or loss | - | 39 | 32 |
Realised gains sub-total | 7 | 48 | 615 |
1,529 | 348 | 1,264 |
4. Investment income
Unaudited six months ended 30 September 2015 £'000 | Unaudited six months ended 30 September 2014 £'000 | Audited year ended 31 March 2015 £'000 | |
Income recognised on investments held at fair value through profit or loss | |||
Loan stock interest | 587 | 531 | 1,114 |
UK dividend income | 50 | 39 | 76 |
Bank deposit interest | 41 | 36 | 68 |
678 | 606 | 1,258 |
All of the Company's income is derived from operations based in the United Kingdom.
5. Investment management fees
Unaudited six months ended 30 September 2015 £'000 | Unaudited six months ended 30 September 2014 £'000 | Audited year ended 31 March 2015 £'000 | |
Investment management fee charged to revenue | 116 | 103 | 210 |
Investment management fee charged to capital | 347 | 309 | 628 |
463 | 412 | 838 |
Further details of the management agreement under which the investment management fee is paid are given in the Strategic report on page 9 of the Annual Report and Financial Statements for the year ended 31 March 2015.
During the period, services of a total value of £463,000 (30 September 2014: £412,000; 31 March 2015: £838,000) were purchased by the Company from Albion Ventures LLP. At the financial period end, the amount due to Albion Ventures LLP in respect of these services disclosed within creditors was £247,000 (30 September 2014: £211,000; 31 March 2015: £216,000).
Patrick Reeve is the Managing Partner of the Manager, Albion Ventures LLP. During the period, the Company was charged £10,800 including VAT (30 September 2014: £10,800; 31 March 2015: £21,600) by Albion Ventures LLP in respect of Patrick Reeve's services as a Director. At the financial period end, the amount due to Albion Ventures LLP in respect of these services disclosed as creditors was £5,400 (30 September 2014: £5,400; 31 March 2015: £5,400).
Albion Ventures LLP is, from time to time, eligible to receive transaction fees and Directors' fees from portfolio companies. During the period to 30 September 2015, fees of £82,000 attributable to the investments of the Company were received pursuant to these arrangements (30 September 2014: £79,000; 31 March 2015: £194,000).
6. Dividends
Unaudited six months ended 30 September 2015 £'000 | Unaudited six months ended 30 September 2014 £'000 | Audited year ended 31 March 2015 £'000 | ||||
Dividend of 2.50p per share paid on 29 August 2014 | - | 875 | 875 | |||
Dividend of 2.50p per share paid on 27 February 2015 | - | - | 916 | |||
Dividend of 2.50p per share paid on 28 August 2015 | 999 | - | - | |||
999 | 875 | 1,791 |
In addition to the dividends summarised above, the Board has declared a second dividend for the year ending 31 March 2016 of 2.50 pence per share which will be paid on 29 February 2016 to shareholders on the register as at 12 February 2016. This is expected to amount to approximately £1,010,000.
7. Basic and diluted return per share
Unaudited six months ended 30 September 2015 | Unaudited six months ended 30 September 2014 | Audited year ended 31 March 2015 | |||||||||
Revenue | Capital | Total | Revenue | Capital | Total | Revenue | Capital | Total | |||
Return attributable to equity shares (£'000) | 371 | 1,251 | 1,622 | 326 | 104 | 430 | 728 | 767 | 1,495 | ||
Weighted average shares in issue (excluding treasury shares) | 39,600,517 | 34,705,763 | 35,154,858 | ||||||||
Return attributable per Ordinary share (pence) (basic and diluted) | 0.94 | 3.16 | 4.10 | 0.94 | 0.30 | 1.24 | 2.07 | 2.18 | 4.25 |
The weighted average number of shares is calculated excluding treasury shares of 5,288,000 (30 September 2014: 4,179,000; 31 March 2015: 4,907,000).
There are no convertible instruments, derivatives or contingent share agreements in issue for the Company, hence there are no dilution effects to the return per share. The basic return per share is therefore the same as the diluted return per share.
8. Called up share capital
Unaudited 30 September 2015 £'000 | Unaudited 30 September 2014 £'000 | Audited 31 March 2015 £'000 | |
Allotted, called up and fully paid 45,702,613 Ordinary shares of 1 penny each (30 September 2014: 39,453,306; 31 March 2015: 40,931,339) | 457 | 395 | 409 |
Voting rights
40,414,613 shares of 1 penny each (net of treasury shares) (30 September 2014: 35,274,306; 31 March 2015: 36,024,339).
In the six months to 30 September 2015, the Company purchased 381,000 shares (30 September 2014: 505,000; 31 March 2015: 1,233,000) to be held in treasury at a cost of £343,000 (30 September 2014: £451,000; 31 March 2015: £1,094,000), representing 0.9 per cent. of the shares in issue (excluding treasury shares) as at 30 September 2015.
The Company holds a total of 5,288,000 shares (30 September 2014: 4,179,000; 31 March 2015: 4,907,000) in treasury representing 11.6 per cent. of the shares in issue as at 30 September 2015.
Under the terms of the Dividend Reinvestment Scheme, Circular dated 26 November 2009, the following Ordinary shares of nominal value 1 penny were allotted during the period to 30 September 2015:
Date of allotment | Number of shares allotted | Aggregate nominal value of shares (£'000) | Issue price (pence per share) | Net consideration received (£'000) | Opening market price on allotment date (pence per share) |
28 August 2015 | 143,182 | 1 | 96.51 | 136 | 90.50 |
Under the terms of the Albion VCTs Prospectus Top Up Offers 2014/2015, the following Ordinary shares of nominal value 1 penny each were allotted during the period to 30 September 2015:
Date of allotment | Number of shares allotted | Aggregate nominal value of shares (£'000) | Issue price (pence per share) | Net consideration received (£'000) | Opening market price on allotment date (pence per share) |
2 April 2015 | 3,295,686 | 33 | 97.40 | 3,114 | 87.50 |
30 June 2015 | 609,587 | 6 | 99.20 | 586 | 87.50 |
30 June 2015 | 37,437 | - | 98.20 | 36 | 87.50 |
30 June 2015 | 11,988 | - | 98.70 | 12 | 87.50 |
30 September 2015 | 673,394 | 7 | 99.50 | 650 | 90.50 |
4,628,092 | 46 | 4,398 |
9. Reconciliation of revenue return on ordinary activities before taxation to net cash flow from operating activities
Unaudited six months ended 30 September 2015 £'000 | Unaudited six months ended 30 September 2014 £'000 | Audited year ended 31 March 2015 £'000 | |
Revenue return on ordinary activities before taxation | 451 | 401 | 847 |
Investment management fee charged to capital | (347) | (309) | (628) |
Movement in accrued amortised loan stock interest | (14) | 4 | (65) |
(Increase)/decrease in debtors | (4) | 7 | 4 |
Increase/(decrease) in creditors | 23 | (5) | 12 |
Corporation tax recovered/(paid) | 35 | - | (15) |
Net cash flow from operating activities | 144 | 98 | 155 |
10. Commitments and contingencies
As at 30 September 2015, the Company had the following financial commitments in respect of investments:
(30 September 2014: £399,000; 31 March 2015: £872,000).
There are no contingent liabilities or guarantees given by the Company as at 30 September 2015 (30 September 2014: £nil, 31 March 2015: £nil).
11. Post balance sheet events
Since 30 September 2015, the Company has had the following post balance sheet events:
Investment of £304,000 in Relayware Limited;
Investment of £211,000 in DySIS Medical Limited;
Investment of £115,000 in Grapeshot Limited;
Investment of £84,000 in Dickson Financial Services Limited (t/a Innovation Broking);
Investment of £80,000 in Panaseer Limited;
Investment of £76,000 in Aridhia Informatics Limited;
Investment of £48,000 in Sandcroft Avenue Limited; and
Investment of £41,000 in Process Systems Enterprise Limited.
On 17 November 2015 the Company announced the publication of a prospectus in relation to an offer for subscription for new Ordinary shares. The Company is aiming to raise circa £4.25 million out of a target of £25.5 million in aggregate that the Albion VCTs are seeking to raise. In addition, the Board may elect to allot up to a further £1.75 million if there is sufficient demand and the Board deems it prudent to do so. The proceeds will be used to provide further resources at a time when a number of attractive investment opportunities are being seen. A Securities Note, which forms part of the Prospectus, will be sent to shareholders shortly.
12. Related party transactions
Other than transactions with the Manager as described in Note 5, there are no other related party transactions.
13. Risks and uncertainties
The Board considers that the Company faces the following principal risks and uncertainties:
1. Economic risk
Changes in economic conditions, including, for example, interest rates, rates of inflation, industry conditions, competition, political and diplomatic events and other factors could substantially and adversely affect the Company's prospects in a number of ways.
To reduce this risk, in addition to investing equity in portfolio companies, the Company often invests in secured loan stock and has a policy of not normally permitting any external bank borrowings within portfolio companies. Additionally, the Manager has been rebalancing the sector exposure of the portfolio with a view to reducing reliance on consumer led sectors.
2. Investment risk
This is the risk of investment in poor quality assets which reduces the capital and income returns to shareholders, and negatively impacts on the Company's reputation. By nature, smaller unquoted businesses, such as those that qualify for venture capital trust purposes, are more fragile than larger, long established businesses.
To reduce this risk, the Board places reliance upon the skills and expertise of the Manager and its strong track record for investing in this segment of the market. In addition, the Manager operates a formal and structured investment process, which includes an Investment Committee, comprising investment professionals from the Manager and at least one external investment professional. The Manager also invites and takes account of comments from non-executive Directors of the Company on investments discussed at the Investment Committee meetings. Investments are actively and regularly monitored by the Manager (investment managers normally sit on portfolio company boards) and the Board receives detailed reports on each investment as part of the Manager's report at quarterly board meetings.
3. Valuation risk
The Company's investment valuation method is reliant on the accuracy and completeness of information that is issued by portfolio companies. In particular, the Directors may not be aware of or take into account certain events or circumstances which occur after the information issued by such companies is reported.
As described in note 2 of the Financial Statements, investments held by the Company are classified at fair value through profit or loss and valued in accordance with the International Private Equity and Venture Capital Valuation Guidelines. These guidelines set out recommendations, intended to represent current best practice on the valuation of venture capital investments. These investments are valued on the basis of forward looking estimates and judgements about the business itself, its market and the environment in which it operates, together with the state of the mergers and acquisitions market, stock market conditions and other factors. In making these judgements the valuation takes into account all known material facts up to the date of approval of the Financial Statements by the Board. The values of a number of investments are also underpinned by independent third party professional valuations.
4. Venture capital trust approval risk
The Company's current approval as a venture capital trust allows investors to take advantage of tax reliefs on initial investment and ongoing tax free capital gains and dividend income. Failure to meet the qualifying requirements could result in investors losing the tax relief on initial investment and loss of tax relief on any tax-free income or capital gains received. In addition, failure to meet the qualifying requirements could result in a loss of listing of the shares.
To reduce this risk, the Board has appointed the Manager, who has a team with significant experience in venture capital trust management, used to operating within the requirements of the venture capital trust legislation. In addition, to provide further formal reassurance, the Board has appointed Robertson Hare LLP (previously PricewaterhouseCoopers LLP) as its taxation advisor. Robertson Hare LLP reports quarterly to the Board to independently confirm compliance with the venture capital trust legislation, to highlight areas of risk and to inform on changes in legislation. Each investment in a new portfolio company is also pre-cleared with H.M. Revenue & Customs.
5. Compliance risk
The Company is listed on The London Stock Exchange and is required to comply with the rules of the UK Listing Authority, as well as with the Companies Act, Accounting Standards and other legislation. Failure to comply with these regulations could result in a delisting of the Company's shares, or other penalties under the Companies Act or from financial reporting oversight bodies.
Board members and the Manager have experience of operating at senior levels within or advising quoted businesses. In addition, the Board and the Manager receive regular updates on new regulation from its auditor, lawyers and other professional bodies.
6. Internal control risk
Failures in key controls, within the Board or within the Manager's business, could put assets of the Company at risk or result in reduced or inaccurate information being passed to the Board or to shareholders.
The Audit Committee meets with the Manager's Internal Auditor, PKF Littlejohn LLP, when required, receiving a report regarding the last formal internal audit performed on the Manager, and providing the opportunity for the Audit Committee to ask specific and detailed questions. Patrick Reeve on behalf of the Chairman of the Audit Committee, met with the internal audit Partner of PKF Littlejohn LLP in January 2015 to discuss the most recent Internal Audit Report on the Manager. The Manager has a comprehensive business continuity plan in place in the event that operational continuity is threatened.
Measures are in place to mitigate information risk in order to ensure the integrity, availability and confidentiality of information used within the business.
7. Reliance upon third parties risk
The Company is reliant upon the services of Albion Ventures LLP for the provision of investment management and administrative functions.
There are provisions within the management agreement for the change of Manager under certain circumstances (for further detail, see the management agreement paragraph on page 9 of the full Annual Report and Financial Statements for the year ended 31 March 2015). In addition, the Manager has demonstrated to the Board that there is no undue reliance placed upon any one individual within Albion Ventures LLP.
8. Financial risk
By its nature, as a venture capital trust, the Company is exposed to investment risk (which comprises investment price risk and cash flow interest rate risk), credit risk and liquidity risk.
The Company's policies for managing these risks and its financial instruments are outlined in full in note 19 of the full Annual Report and Financial Statements for the year ended 31 March 2015.
All of the Company's income and expenditure is denominated in sterling and hence the Company has no foreign currency risk. The Company is financed through equity and does not have any borrowings. The Company does not use derivative financial instruments for speculative purposes.
14. Going concern
The Board's assessment of liquidity risk remains unchanged since the last Annual Report and Financial Statements for the year ended 31 March 2015, and is detailed on pages 50 and 51 of those accounts. The Company has adequate cash and liquid resources and has no borrowing. The portfolio of investments is diversified in terms of sector, and the major cash outflows of the Company (namely investments, share buy-backs and dividends) are within the Company's control. Accordingly, after making diligent enquiries, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. For this reason, the Directors have adopted the going concern basis in preparing this Half-yearly Financial Report and this is in accordance with 'Going Concern and Liquidity Risk: Guidance for Directors of UK Companies 2009' published by the Financial Reporting Council.
15. Other information
The information set out in this Half-yearly Financial Report does not constitute the Company's statutory accounts within the terms of section 435 of the Companies Act 2006 for the periods ended 30 September 2015 and 30 September 2014, and is unaudited. The information for the year ended 31 March 2015 does not constitute statutory accounts within the terms of section 435 of the Companies Act 2006 but is derived from the statutory accounts for the financial year, which were unqualified and have been delivered to the Registrar of Companies. The Auditor reported on those accounts; their report was unqualified and did not contain statements under s498 (2) or (3) of the Companies Act 2006.
16. Publication
This Half-yearly Financial Report is being sent to shareholders and copies will be made available to the public at the registered office of the Company, Companies House, the National Storage Mechanism and also electronically at www.albion-ventures.co.uk/ourfunds/AAEV.htm.